UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High incidence of cytokine release syndrome in patients with advanced NSCLC treated with nivolumab plus ipilimumab

Annals of oncology, 2023-11, Vol.34 (11), p.1064-1065

2023

Volltextzugriff (PDF)

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

Annals of oncology, 2016-12, Vol.27 (12), p.2242-2250

2016

Volltextzugriff (PDF)

Occurrence of azoxystrobin‐resistant isolates in Passalora fulva, the pathogen of tomato leaf mould disease

Plant pathology, 2017-12, Vol.66 (9), p.1472-1479

2017

Volltextzugriff (PDF)

583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study

Annals of oncology, 2020-09, Vol.31, p.S494-S494

2020

Volltextzugriff (PDF)

Haemoglobin‐vesicles as artificial oxygen carriers: present situation and future visions

Journal of internal medicine, 2008-01, Vol.263 (1), p.4-15

2008

Volltextzugriff (PDF)

Efficacy and safety of epidermal growth factor receptor (EGFR) - Tyrosine kinase inhibitors (TKI) in elderly patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-11, Vol.29, p.ix160-ix161

2018

Volltextzugriff (PDF)

Association of immune-related pneumonitis with the phenotypic appearance of concurrent ILD in patients treated with anti-PD-1 antibody

Annals of oncology, 2018-11, Vol.29, p.ix165-ix165

2018

Volltextzugriff (PDF)

Optimal interval from preceding radiotherapy (RT) to enhance efficacy of immune check point inhibitors (ICIs): Consecutive analysis of 294 patients with non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii542-viii543

2018

Volltextzugriff (PDF)

Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases

ESMO open, 2023-08, Vol.8 (4), p.101594-101594, Article 101594

2023

Volltextzugriff (PDF)

Safety and tolerability of pembrolizumab or placebo plus pemetrexed and platinum as first-line therapy in Japanese patients (PTS) with metastatic non-squamous non-small cell lung cancer (NSCLC) enrolled in the phase III KEYNOTE-189 study

Annals of oncology, 2019-04, Vol.30, p.ii56-ii57

2019

Volltextzugriff (PDF)

Determination of hydrogen diffusion and permeation coefficients in pure copper at near room temperature by means of tritium tracer techniques

Journal of alloys and compounds, 2013-12, Vol.580, p.S73-S75

2013

Volltextzugriff (PDF)

MS 23.03 What is Resectable N2 Disease, and What is Unresectable N2 Disease: A Medical Oncologist's Viewpoint

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1718-S1719

Horinouchi, H.

2017

Volltextzugriff (PDF)

Relationships between lenvatinib plasma concentration and toxicity in Japanese cancer patients

Annals of oncology, 2018-11, Vol.29, p.ix23-ix23

2018

Volltextzugriff (PDF)

Clinical courses of patients with small cell lung cancer after complete resection followed by adjuvant chemotherapy

Annals of oncology, 2018-11, Vol.29, p.ix141-ix141

2018

Volltextzugriff (PDF)

Hydrogen permeation in iron and nickel alloys around room temperature

Journal of nuclear materials, 2013-11, Vol.442 (1-3), p.S726-S729

2013

Volltextzugriff (PDF)

Percutaneous transfer of an acute popliteal artery embolism to a deep femoral artery using balloon embolectomy technique: initial results

Journal of vascular and interventional radiology, 2016-03, Vol.27 (3), p.S100-S100

2016

Volltextzugriff (PDF)

Control of Fusarium crown and root rot of tomato in a soil system by combination of a plant growth-promoting fungus, Fusarium equiseti, and biodegradable pots

Crop protection, 2008-03, Vol.27 (3), p.859-864

2008

Volltextzugriff (PDF)

Fusarium equiseti GF191 as an effective biocontrol agent against Fusarium crown and root rot of tomato in rock wool systems

Crop protection, 2007-10, Vol.26 (10), p.1514-1523

2007

Volltextzugriff (PDF)

Adrenal function in patients with community-acquired pneumonia

The European respiratory journal, 2008-06, Vol.31 (6), p.1268-1273

2008

Volltextzugriff (PDF)

BIOCONTROL OF FUSARIUM WILT OF SPINACH BY THE PLANT GROWTH PROMOTING FUNGUS FUSARIUM EQUISETI GF183

Journal of plant pathology, 2010-03, Vol.92 (1), p.249-254

2010

Volltextzugriff (PDF)

1393TiP A phase II/III study to evaluate the optimal dose, safety, and efficacy of livmoniplimab (Livmo) in combination with budigalimab (Budi) plus chemotherapy (CT) vs pembrolizumab (Pembro) plus CT in untreated metastatic non-small cell lung cancer (mNSCLC)

Annals of oncology, 2024-09, Vol.35, p.S872-S872

2024

Volltextzugriff (PDF)

502P Impact of sarcopenia on the outcome of patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab

Annals of oncology, 2023-11, Vol.34, p.S1659

2023

Volltextzugriff (PDF)

1920P Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitors

Annals of oncology, 2024-09, Vol.35, p.S1117-S1117

2024

Volltextzugriff (PDF)

1495P Impact of social isolation on the clinical outcomes in advanced NSCLC patients

Annals of oncology, 2024-09, Vol.35, p.S918-S919

2024

Volltextzugriff (PDF)

387P Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study

Annals of oncology, 2022-11, Vol.33, p.S1592

2022

Volltextzugriff (PDF)

1 – 25 von 501

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(427)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(200)
Biological And Medical Sciences
(126)
Humans
(112)
Male
(84)
Fundamental And Applied Biological Sciences. Psychology
(80)
Female
(69)
Animals
(65)
Molecular Sequence Data
(57)
Microbiology
(56)
Base Sequence
(53)
Medical Sciences
(51)
Physical Sciences
(51)
Biochemistry & Molecular Biology
(49)
Amino Acid Sequence
(48)
Middle Aged
(47)
Aged
(43)
Biotechnology & Applied Microbiology
(41)
Adult
(40)
Cloning, Molecular
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

High incidence of cytokine release syndrome in patients with advanced NSCLC treated with nivolumab plus ipilimumab

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study

Occurrence of azoxystrobin‐resistant isolates in Passalora fulva, the pathogen of tomato leaf mould disease

583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study

Haemoglobin‐vesicles as artificial oxygen carriers: present situation and future visions

Efficacy and safety of epidermal growth factor receptor (EGFR) - Tyrosine kinase inhibitors (TKI) in elderly patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)

Association of immune-related pneumonitis with the phenotypic appearance of concurrent ILD in patients treated with anti-PD-1 antibody

Optimal interval from preceding radiotherapy (RT) to enhance efficacy of immune check point inhibitors (ICIs): Consecutive analysis of 294 patients with non-small cell lung cancer (NSCLC)

Comparison of clinical outcomes of osimertinib and first-generation EGFR-tyrosine kinase inhibitors (TKIs) in TKI-untreated EGFR-mutated non-small-cell lung cancer with leptomeningeal metastases

Safety and tolerability of pembrolizumab or placebo plus pemetrexed and platinum as first-line therapy in Japanese patients (PTS) with metastatic non-squamous non-small cell lung cancer (NSCLC) enrolled in the phase III KEYNOTE-189 study

Determination of hydrogen diffusion and permeation coefficients in pure copper at near room temperature by means of tritium tracer techniques

MS 23.03 What is Resectable N2 Disease, and What is Unresectable N2 Disease: A Medical Oncologist's Viewpoint

Relationships between lenvatinib plasma concentration and toxicity in Japanese cancer patients

Clinical courses of patients with small cell lung cancer after complete resection followed by adjuvant chemotherapy

Hydrogen permeation in iron and nickel alloys around room temperature

Percutaneous transfer of an acute popliteal artery embolism to a deep femoral artery using balloon embolectomy technique: initial results

Control of Fusarium crown and root rot of tomato in a soil system by combination of a plant growth-promoting fungus, Fusarium equiseti, and biodegradable pots

Fusarium equiseti GF191 as an effective biocontrol agent against Fusarium crown and root rot of tomato in rock wool systems

Adrenal function in patients with community-acquired pneumonia

BIOCONTROL OF FUSARIUM WILT OF SPINACH BY THE PLANT GROWTH PROMOTING FUNGUS FUSARIUM EQUISETI GF183

1393TiP A phase II/III study to evaluate the optimal dose, safety, and efficacy of livmoniplimab (Livmo) in combination with budigalimab (Budi) plus chemotherapy (CT) vs pembrolizumab (Pembro) plus CT in untreated metastatic non-small cell lung cancer (mNSCLC)

502P Impact of sarcopenia on the outcome of patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab

1920P Multiomics analysis of malignant pleural mesothelioma and the effect of immune checkpoint inhibitors

1495P Impact of social isolation on the clinical outcomes in advanced NSCLC patients

387P Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study

Suchergebnisse filtern